drugset / Trial / NCT01391403
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Phase 3
Completed
88 enrolled
Beijing HuiLongGuan Hospital
Stanley Medical Research Institute · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will determine the effectiveness of artemisinin plus risperidone in improving symptoms and cognitive disturbances and in Chinese people with schizophrenia. The study addresses the Toxoplasma infection hypothesis of schizophrenia.
Timeline
- Start
- 2008-09
- Primary completion
- 2011-04
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artemisinin | Small molecule | 400 mg | — |